These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8344147)

  • 61. Serotonin receptor subtypes and affective disorders.
    Robinson DS
    Clin Neuropharmacol; 1993; 16 Suppl 3():S1-5. PubMed ID: 8131151
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel serotonergic agents.
    Nichols DE; Marona-Lewicka D; Huang X; Johnson MP
    Drug Des Discov; 1993; 9(3-4):299-312. PubMed ID: 8400010
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Consequences of 5-HT re-uptake blockade on postsynaptic 5-HT1A receptor activation: an electrophysiological and neurochemical study in guinea pig dorsal raphe and hippocampus.
    Sprouse J; Braselton J; Reynolds L; Clarke T; Rollema H
    Ann N Y Acad Sci; 1998 Dec; 861():272-3. PubMed ID: 9928286
    [No Abstract]   [Full Text] [Related]  

  • 64. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):817-27. PubMed ID: 9259011
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
    Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Endogenous serotonin modulates histamine release in the rat hypothalamus as measured by in vivo microdialysis.
    Laitinen KS; Tuomisto L; Laitinen JT
    Eur J Pharmacol; 1995 Oct; 285(2):159-64. PubMed ID: 8566134
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus.
    Starkey SJ; Skingle M
    Neuropharmacology; 1994; 33(3-4):393-402. PubMed ID: 7984277
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
    Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
    PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats.
    Salchner P; Singewald N
    Psychopharmacology (Berl); 2006 Apr; 185(3):282-8. PubMed ID: 16521035
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 5-HT3 receptors: pharmacologic and therapeutic aspects.
    Gyermek L
    J Clin Pharmacol; 1995 Sep; 35(9):845-55. PubMed ID: 8786244
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of serotonin receptor subtypes in treating depression: a review of animal studies.
    Carr GV; Lucki I
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):265-87. PubMed ID: 21107537
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor.
    Shelton J; Bonaventure P; Li X; Yun S; Lovenberg T; Dugovic C
    Neuropharmacology; 2009 Feb; 56(2):448-54. PubMed ID: 18948124
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
    J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
    Redrobe JP; Bourin M; Colombel MC; Baker GB
    J Psychopharmacol; 1998; 12(4):348-55. PubMed ID: 10065908
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides.
    Jørgensen H; Kjaer A; Knigge U; Møller M; Warberg J
    J Neuroendocrinol; 2003 Jun; 15(6):564-71. PubMed ID: 12716407
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesis.
    Moret C; Briley M
    J Neural Transm (Vienna); 1997; 104(2-3):147-60. PubMed ID: 9203078
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

  • 79. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of chronic paroxetine treatment on 5-HT1B and 5-HT1D autoreceptors in rat dorsal raphe nucleus.
    Davidson C; Stamford JA
    Neurochem Int; 2000 Feb; 36(2):91-6. PubMed ID: 10676872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.